首页> 外文期刊>Journal of organ dysfunction >Hyponatremia in critical illness
【24h】

Hyponatremia in critical illness

机译:低危血症

获取原文
获取原文并翻译 | 示例
       

摘要

Hyponatremia is the commonest electrolyte disorder in hospitalized patients and is associated with increased morbidity and mortality. Although most patients are asymptomatic at presentation, many present neurological symptoms which can easily be overlooked and have the potential to progress and produce neurological sequelae, and even death, if not diagnosed and treated promptly. The classification of hyponatremia is based on serum osmolality and the volume status of the patient. When iatrogenic causes are excluded, inadequate secretion of antidiuretic hormone and cerebral salt wasting are the commonest mechanisms of hyponatremia in neurological and critically ill patients and their differentiation is crucial because they require drastically different management. The risks of overly rapid correction (which mostly comprise osmotic demyelination) must be borne in mind when treating hyponatremia. Management mainly depends on the speed of onset of hyponatremia and the presence of symptoms. Vasopressin antagonists have recently been introduced into clinical practice with promising results. More randomized studies are needed to determine the optimal role of these new agents in the treatment of hyponatremia.
机译:低钠血症是住院患者中最常见的电解质紊乱,并与发病率和死亡率增加有关。尽管大多数患者表现出无症状,但许多人表现出的神经系统症状很容易被忽视,如果不及时诊断和治疗,可能会发展并产生神经系统后遗症甚至死亡。低钠血症的分类基于血清渗透压和患者的身体状况。如果排除医源性原因,抗利尿激素分泌不足和脑盐浪费是神经系统疾病和重症患者低钠血症的最常见机制,而它们的分化至关重要,因为它们需要完全不同的管理。治疗低钠血症时,必须牢记过度快速矫正的风险(主要包括渗透性脱髓鞘)。处理主要取决于低钠血症的发作速度和症状的存在。加压素拮抗剂最近已被引入临床实践,并取得了可喜的结果。需要更多随机研究来确定这些新药在低钠血症治疗中的最佳作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号